• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Life-threatening hypocalcaemia associated with denosumab in advanced chronic kidney disease.

作者信息

Killen J P, Yong K, Luxton G, Endre Z

机构信息

Department of Renal Medicine, Prince of Wales Hospital, Sydney, New South Wales, Australia.

出版信息

Intern Med J. 2016 Jun;46(6):746-7. doi: 10.1111/imj.13097.

DOI:10.1111/imj.13097
PMID:27257154
Abstract
摘要

相似文献

1
Life-threatening hypocalcaemia associated with denosumab in advanced chronic kidney disease.晚期慢性肾脏病中与地诺单抗相关的危及生命的低钙血症
Intern Med J. 2016 Jun;46(6):746-7. doi: 10.1111/imj.13097.
2
Hypercalcaemia-induced acute kidney injury in an older patient with osteoporosis treated with alfacalcidol for denosumab-induced hypocalcaemia.在一名老年骨质疏松症患者中，因地诺单抗诱导的低钙血症而接受阿法骨化醇治疗后出现高钙血症诱导的急性肾损伤。
Nephrology (Carlton). 2017 Jul;22(7):572-573. doi: 10.1111/nep.12843.
3
Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.地诺单抗相关低钙血症：三级医院环境中的发病率、严重程度及患者特征
Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1274-1278. doi: 10.1002/pds.4045. Epub 2016 Jun 3.
4
Extreme hypocalcaemia and hyperparathyroidism following denosumab. Is this drug safe in chronic kidney disease?地诺单抗治疗后出现严重低钙血症和甲状旁腺功能亢进。这种药物在慢性肾病中安全吗？
Nefrologia. 2014;34(4):542-4. doi: 10.3265/Nefrologia.pre2014.Mar.12383.
5
Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease.接受地舒单抗治疗的慢性肾脏病患者发生严重低钙血症。
Am J Med Sci. 2018 May;355(5):506-509. doi: 10.1016/j.amjms.2017.09.008. Epub 2017 Sep 20.
6
Safety of denosumab in dialysis patients on calcium and vitamin D supplements.地诺单抗在接受钙和维生素D补充剂治疗的透析患者中的安全性。
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):158-161. doi: 10.4103/1319-2442.198240.
7
Hypocalcaemia after denosumab in older people following fracture.骨折后老年人使用地舒单抗后低钙血症。
Osteoporos Int. 2017 Feb;28(2):517-522. doi: 10.1007/s00198-016-3755-8. Epub 2016 Sep 28.
8
Denosumab anf cronic kidney disease: Severe life-threatening hypocalcemia.地诺单抗与慢性肾脏病：严重危及生命的低钙血症
Nefrologia (Engl Ed). 2018 Jan-Feb;38(1):97-98. doi: 10.1016/j.nefro.2017.01.004.
9
Acute hypocalcaemia following denosumab in heart and lung transplant patients with osteoporosis.地诺单抗治疗后，合并骨质疏松的心肺移植患者出现急性低钙血症。
Intern Med J. 2018 Jun;48(6):681-687. doi: 10.1111/imj.13744.
10
Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report.地舒单抗治疗慢性肾脏病患者后严重低钙血症：1 例报告。
J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):285-289.

引用本文的文献

1
Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases.地诺单抗在透析患者中使用时甲状旁腺激素反应的对比：2例报告
Pharmacy (Basel). 2020 Apr 1;8(2):59. doi: 10.3390/pharmacy8020059.
2
Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.地诺单抗给药导致的严重症状性低钙血症：治疗与临床过程
Case Rep Nephrol Dial. 2019 Apr 23;9(1):33-41. doi: 10.1159/000499824. eCollection 2019 Jan-Apr.
3
Denosumab for the treatment of osteoporosis.地诺单抗用于治疗骨质疏松症。
Osteoporos Sarcopenia. 2017 Mar;3(1):8-17. doi: 10.1016/j.afos.2017.01.002. Epub 2017 Feb 15.
4
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.接受双膦酸盐或地舒单抗治疗的前列腺癌患者的低钙血症：预防支持治疗完成。
BMC Urol. 2018 Sep 20;18(1):81. doi: 10.1186/s12894-018-0393-9.
5
Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.地舒单抗治疗终末期肾病患者后的低钙血症和骨密度变化：观察性研究的荟萃分析。
Osteoporos Int. 2018 Aug;29(8):1737-1745. doi: 10.1007/s00198-018-4533-6. Epub 2018 Apr 30.